Page last updated: 2024-09-03

ah 6809 and Asthma, Bronchial

ah 6809 has been researched along with Asthma, Bronchial in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belvisi, MG; Birrell, MA; Buckley, J; Clarke, DL; Maher, SA; Nials, AT1
Arthur, GK; Bradding, P; Brightling, CE; Jones, DJ; Martin, N; Pavord, ID; Ruddick, A; Wan, H; Woodman, L1

Other Studies

2 other study(ies) available for ah 6809 and Asthma, Bronchial

ArticleYear
EP4 receptor as a new target for bronchodilator therapy.
    Thorax, 2011, Volume: 66, Issue:12

    Topics: Alprostadil; Animals; Asthma; Bridged Bicyclo Compounds, Heterocyclic; Bronchodilator Agents; Dinoprostone; Fatty Acids, Unsaturated; Guinea Pigs; Humans; Hydrazines; Macaca fascicularis; Methyl Ethers; Mice; Mice, Inbred C57BL; Naphthalenes; Phenylbutyrates; Prostanoic Acids; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin E; Regression Analysis; Species Specificity; Trachea; Xanthones

2011
Primary human airway epithelial cell-dependent inhibition of human lung mast cell degranulation.
    PloS one, 2012, Volume: 7, Issue:8

    Topics: Asthma; Cell Degranulation; Cells, Cultured; Coculture Techniques; Docosahexaenoic Acids; Epithelial Cells; Histamine Release; Humans; Immunoglobulin E; Inflammation Mediators; Limit of Detection; Lipoxins; Lung; Mast Cells; Paracrine Communication; Pertussis Toxin; Receptors, Prostaglandin E, EP2 Subtype; Respiratory Mucosa; Xanthones

2012